Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol.
about
In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles.Magnetic Nanoparticles in Cancer TheranosticsSynthesis, characterization, applications, and challenges of iron oxide nanoparticles.Exploring the tumor microenvironment with nanoparticlesRegenerative nanomedicine: current perspectives and future directions.Magnetite nanoparticles inhibit tumor growth and upregulate the expression of p53/p16 in Ehrlich solid carcinoma bearing miceLipophilic prodrug conjugates allow facile and rapid synthesis of high-loading capacity liposomes without the need for post-assembly purification.In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticlesDelivery of acetylthevetin B, an antitumor cardiac glycoside, using polymeric micelles for enhanced therapeutic efficacy against lung cancer cells.Tracking stem cells in tissue-engineered organs using magnetic nanoparticles.Exploiting the novel properties of protein coronas: emerging applications in nanomedicine.An update on clinical applications of magnetic nanoparticles for increasing the resolution of magnetic resonance imaging.The responses of immune cells to iron oxide nanoparticles.Formulation design facilitates magnetic nanoparticle delivery to diseased cells and tissuesExposure to Iron Oxide Nanoparticles Coated with Phospholipid-Based Polymeric Micelles Induces Biochemical and Histopathological Pulmonary Changes in Mice.Development, Optimization, and Characterization of PEGylated Nanoemulsion of Prostaglandin E1 for Long Circulation.Nanoparticle Biokinetics in Mice and Nonhuman Primates.Prospects for magnetic nanoparticles in systemic administration: synthesis and quantitative detection.Advances in Magnetic Nanoparticles for Biomedical Applications.Uptake and transcytosis of functionalized superparamagnetic iron oxide nanoparticles in an in vitro blood brain barrier model.Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice.Pharmacokinetics and bio-distribution of novel super paramagnetic iron oxide nanoparticles (SPIONs) in the anaesthetized pig.Magnetic resonance imaging of post-ischemic blood-brain barrier damage with PEGylated iron oxide nanoparticles.Quantitative histochemistry for macrophage biodistribution on mice liver and spleen after the administration of a pharmacological-relevant dose of polyacrylic acid-coated iron oxide nanoparticles.Time-dependent biodistribution, clearance and biocompatibility of magnetic fibrin nanoparticles: an in vivo study.A fast and reproducible method to quantify magnetic nanoparticle biodistribution.Ferritin Protein Regulates the Degradation of Iron Oxide Nanoparticles.Biotransformation of magnetic nanoparticles as a function of coating in a rat model.Delayed hepatic uptake of multi-phosphonic acid poly(ethylene glycol) coated iron oxide measured by real-time magnetic resonance imaging
P2860
Q26779017-D56396BE-4BBC-445E-B1A1-A0043765DF73Q26784379-2AD8A12E-C828-4A0C-A240-1ECB6A524A98Q27014954-3E805B38-B141-46E0-B308-E9FBEB4F5C19Q28082374-20A91F96-1C73-488A-BE1D-C2BBF45F1EE8Q34156132-BDA2D332-127B-41C6-A4E1-4A579DE0EBE6Q34465935-DD038302-65BC-4C44-83D2-6AF3C483AFF0Q35773072-88511335-24A6-45E0-8DC2-D29C3AB3F97DQ36289257-475985AD-F1EC-44E3-A926-357340D81EFAQ37642547-8CD785D0-06AF-46F4-94CB-684932457AAAQ38151018-573C9DE5-06EB-4FAC-A0EB-58D93DD7A7CCQ38501675-1CB5E551-8341-4391-8ACC-FB04ADEB4BFAQ38638717-4BBC1E1A-23A6-45BD-8983-E0853B62B564Q38799107-6F9809D3-E118-40EB-8FB8-2DD6264776ABQ41834840-EA3CFB61-690A-4972-BB4A-C12FDC3F3053Q41865534-92A0F51D-56D2-49CF-A819-9D35D806CC11Q42356654-618C6B1A-F3CA-4FB0-A71E-A7151A05C632Q46310258-AA702A52-0E5C-4905-A351-B6B2BA268163Q46940439-6472DD7B-A71B-4897-8E8B-F22572B7D124Q47216873-6D92DAC2-A086-4BDF-A2D2-F7B781E1F377Q47251170-C94D771F-4178-42FC-B4AF-FBBBDED872D1Q47424149-826FD042-0341-425B-B6DD-8FD2A03BD4F9Q47610824-F83E5E28-F730-406F-954A-A5E559E05738Q48464541-2F55591B-7C6C-4F43-BD28-80C446A4E169Q50187007-CA026FBC-6BAB-4172-8F4D-43D5F834260BQ50214231-A86C436F-9396-495E-907B-D43FF354A121Q50226062-0CBB2380-857B-47E5-AA71-86878DE5F004Q51212493-6C3E99D4-E763-495C-B0C2-B7A6D5933A6AQ53346868-EA5CE230-0804-42DD-8C92-2094114CE1EDQ57377169-92E3A8BF-D01A-430F-9319-1E1605B0BF02
P2860
Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Biodistribution and pharmacoki ...... fied with polyethylene glycol.
@ast
Biodistribution and pharmacoki ...... fied with polyethylene glycol.
@en
type
label
Biodistribution and pharmacoki ...... fied with polyethylene glycol.
@ast
Biodistribution and pharmacoki ...... fied with polyethylene glycol.
@en
prefLabel
Biodistribution and pharmacoki ...... fied with polyethylene glycol.
@ast
Biodistribution and pharmacoki ...... fied with polyethylene glycol.
@en
P2093
P2860
P50
P356
P1433
P1476
Biodistribution and pharmacoki ...... ified with polyethylene glycol
@en
P2093
E Martínez
M P Morales
Y Hernández
P2860
P304
11400-11408
P356
10.1039/C3NR01412F
P407
P577
2013-07-05T00:00:00Z